{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T02:01:37Z","timestamp":1744164097616,"version":"3.37.3"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T00:00:00Z","timestamp":1613001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100010293","name":"Seattle Genetics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010293","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s00520-021-06044-9","type":"journal-article","created":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T05:05:35Z","timestamp":1613106335000},"page":"4987-4996","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The patient experience of ABVD treatment in Hodgkin lymphoma: a retrospective cohort study of patient-reported distress"],"prefix":"10.1007","volume":"29","author":[{"given":"Aaron M.","family":"Tarnasky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse D.","family":"Troy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0546-7895","authenticated-orcid":false,"given":"Thomas W.","family":"LeBlanc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,11]]},"reference":[{"key":"6044_CR1","unstructured":"Cancer Stat Facts: Hodgkin Lymphoma National Cancer Institute: SEER Program. https:\/\/seer.cancer.gov\/statfacts\/html\/hodg.html. Accessed 15 April 2020"},{"issue":"23","key":"6044_CR2","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.1182\/blood-2014-05-579193","volume":"124","author":"AK Ng","year":"2014","unstructured":"Ng AK (2014) Current survivorship recommendations for patients with Hodgkin lymphoma: focus on late effects. Blood 124(23):3373\u20133379. https:\/\/doi.org\/10.1182\/blood-2014-05-579193","journal-title":"Blood"},{"issue":"10","key":"6044_CR3","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.6004\/jnccn.2019.0048","volume":"17","author":"MBDK Riba","year":"2019","unstructured":"Riba MBDK, Andersen B et al (2019) Distress Management, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw 17(10):1229\u20131249. https:\/\/doi.org\/10.6004\/jnccn.2019.0048","journal-title":"J Natl Compr Cancer Netw"},{"key":"6044_CR4","doi-asserted-by":"publisher","unstructured":"Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S (2001) The prevalence of psychological distress by cancer site. Psychooncology 10(1):19\u201328. https:\/\/doi.org\/10.1002\/1099-1611(200101\/02)10:1<19::aid-pon501>3.0.co;2-6","DOI":"10.1002\/1099-1611(200101\/02)10:1<19::aid-pon501>3.0.co;2-6"},{"issue":"18","key":"6044_CR5","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1200\/jco.2003.01.044","volume":"21","author":"PA Ganz","year":"2003","unstructured":"Ganz PA, Moinpour CM, Pauler DK, Kornblith AB, Gaynor ER, Balcerzak SP, Gatti GS, Erba HP, McCoy S, Press OW, Fisher RI (2003) Health status and quality of life in patients with early-stage Hodgkin\u2019s disease treated on Southwest Oncology Group Study 9133. J Clin Oncol 21(18):3512\u20133519. https:\/\/doi.org\/10.1200\/jco.2003.01.044","journal-title":"J Clin Oncol"},{"issue":"12","key":"6044_CR6","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1007\/s00520-014-2290-4","volume":"22","author":"C-K Fang","year":"2014","unstructured":"Fang C-K, Chang M-C, Chen P-J, Lin C-C, Chen G-S, Lin J, Hsieh R-K, Chang Y-F, Chen H-W, Wu C-L, Lin K-C, Chiu Y-J, Li Y-C (2014) A correlational study of suicidal ideation with psychological distress, depression, and demoralization in patients with cancer. Support Care Cancer 22(12):3165\u20133174. https:\/\/doi.org\/10.1007\/s00520-014-2290-4","journal-title":"Support Care Cancer"},{"issue":"26","key":"6044_CR7","doi-asserted-by":"publisher","first-page":"4346","DOI":"10.1200\/JCO.2008.19.9463","volume":"27","author":"A Hurria","year":"2009","unstructured":"Hurria A, Li D, Hansen K, Patil S, Gupta R, Nelson C, Lichtman SM, Tew WP, Hamlin P, Zuckerman E, Gardes J, Limaye S, Lachs M, Kelly E (2009) Distress in older patients with cancer. J Clin Oncol 27(26):4346\u20134351. https:\/\/doi.org\/10.1200\/JCO.2008.19.9463","journal-title":"J Clin Oncol"},{"issue":"7","key":"6044_CR8","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1002\/pon.3170","volume":"22","author":"Y Wang","year":"2013","unstructured":"Wang Y, Zou L, Jiang M, Wei Y, Jiang Y (2013) Measurement of distress in Chinese inpatients with lymphoma. Psycho-Oncology 22(7):1581\u20131586. https:\/\/doi.org\/10.1002\/pon.3170","journal-title":"Psycho-Oncology"},{"issue":"7","key":"6044_CR9","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/pon.993","volume":"15","author":"S Ransom","year":"2006","unstructured":"Ransom S, Jacobsen PB, Booth-Jones M (2006) Validation of the distress thermometer with bone marrow transplant patients. Psycho-Oncology 15(7):604\u2013612. https:\/\/doi.org\/10.1002\/pon.993","journal-title":"Psycho-Oncology"},{"issue":"18","key":"6044_CR10","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1200\/jco.2016.70.9410","volume":"35","author":"S Sasse","year":"2017","unstructured":"Sasse S, Brockelmann PJ, Goergen H, Plutschow A, Muller H, Kreissl S, Buerkle C, Borchmann S, Fuchs M, Borchmann P, Diehl V, Engert A (2017) Long-term follow-up of contemporary treatment in early-stage Hodgkin lymphoma: updated analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials. J Clin Oncol 35(18):1999\u20132007. https:\/\/doi.org\/10.1200\/jco.2016.70.9410","journal-title":"J Clin Oncol"},{"issue":"7","key":"6044_CR11","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1056\/NEJMoa1000067","volume":"363","author":"A Engert","year":"2010","unstructured":"Engert A, Plutschow A, Eich HT, Lohri A, Dorken B, Borchmann P, Berger B, Greil R, Willborn KC, Wilhelm M, Debus J, Eble MJ, Sokler M, Ho A, Rank A, Ganser A, Trumper L, Bokemeyer C, Kirchner H, Schubert J, Kral Z, Fuchs M, Muller-Hermelink HK, Muller RP, Diehl V (2010) Reduced treatment intensity in patients with early-stage Hodgkin\u2019s lymphoma. N Engl J Med 363(7):640\u2013652. https:\/\/doi.org\/10.1056\/NEJMoa1000067","journal-title":"N Engl J Med"},{"issue":"17","key":"6044_CR12","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1056\/NEJMoa1408648","volume":"372","author":"J Radford","year":"2015","unstructured":"Radford J, Illidge T, Counsell N, Hancock B, Pettengell R, Johnson P, Wimperis J, Culligan D, Popova B, Smith P, McMillan A, Brownell A, Kruger A, Lister A, Hoskin P, O'Doherty M, Barrington S (2015) Results of a trial of PET-directed therapy for early-stage Hodgkin\u2019s lymphoma. N Engl J Med 372(17):1598\u20131607. https:\/\/doi.org\/10.1056\/NEJMoa1408648","journal-title":"N Engl J Med"},{"issue":"3","key":"6044_CR13","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1056\/NEJMoa1100340","volume":"365","author":"S Viviani","year":"2011","unstructured":"Viviani S, Zinzani PL, Rambaldi A, Brusamolino E, Levis A, Bonfante V, Vitolo U, Pulsoni A, Liberati AM, Specchia G, Valagussa P, Rossi A, Zaja F, Pogliani EM, Pregno P, Gotti M, Gallamini A, Rota Scalabrini D, Bonadonna G, Gianni AM (2011) ABVD versus BEACOPP for Hodgkin\u2019s lymphoma when high-dose salvage is planned. N Engl J Med 365(3):203\u2013212. https:\/\/doi.org\/10.1056\/NEJMoa1100340","journal-title":"N Engl J Med"},{"issue":"8","key":"6044_CR14","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1093\/annonc\/mdu189","volume":"25","author":"N Mounier","year":"2014","unstructured":"Mounier N, Brice P, Bologna S, Briere J, Gaillard I, Heczko M, Gabarre J, Casasnovas O, Jaubert J, Colin P, Delmer A, Devidas A, Bachy E, Nicolas-Virelizier E, Aoudjhane A, Humbrecht C, Andre M, Carde P (2014) ABVD (8 cycles) versus BEACOPP (4 escalated cycles >\/= 4 baseline): final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trial. Ann Oncol 25(8):1622\u20131628. https:\/\/doi.org\/10.1093\/annonc\/mdu189","journal-title":"Ann Oncol"},{"issue":"17","key":"6044_CR15","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1200\/jco.2015.64.5648","volume":"34","author":"P Carde","year":"2016","unstructured":"Carde P, Karrasch M, Fortpied C, Brice P, Khaled H, Casasnovas O, Caillot D, Gaillard I, Bologna S, Ferme C, Lugtenburg PJ, Morschhauser F, Aurer I, Coiffier B, Meyer R, Seftel M, Wolf M, Glimelius B, Sureda A, Mounier N (2016) Eight cycles of ABVD versus four cycles of BEACOPPescalated plus four cycles of BEACOPPbaseline in stage III to IV, International Prognostic Score >\/= 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial. J Clin Oncol 34(17):2028\u20132036. https:\/\/doi.org\/10.1200\/jco.2015.64.5648","journal-title":"J Clin Oncol"},{"key":"6044_CR16","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1590\/1982-0194201800085","volume":"31","author":"KRS Louzada","year":"2018","unstructured":"Louzada KRS, Brevidelli MM, Baiocchi O, Domenico EBLD (2018) Aconselhamento telef\u00f4nico: identifica\u00e7\u00e3o de sintomas em pacientes com linfoma em quimioterapia antineopl\u00e1sica. Acta Paul Enferm 31:616\u2013626","journal-title":"Acta Paul Enferm"},{"key":"6044_CR17","unstructured":"Cleeland CS (2016) The M.D. Anderson Symptom Inventory. User Guide. Version 1. The University of Texas MD Anderson Cancer Center. https:\/\/www.mdanderson.org\/content\/dam\/mdanderson\/documents\/Departments-and-Divisions\/Symptom-Research\/MDASI_userguide.pdf. Accessed 20 April 2020"},{"issue":"7","key":"6044_CR18","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1007\/s00520-018-4523-4","volume":"27","author":"JD Troy","year":"2019","unstructured":"Troy JD, Locke SC, Samsa GP, Feliciano J, Richhariya A, LeBlanc TW (2019) Patient-reported distress in Hodgkin lymphoma across the survivorship continuum. Support Care Cancer 27(7):2453\u20132462. https:\/\/doi.org\/10.1007\/s00520-018-4523-4","journal-title":"Support Care Cancer"},{"issue":"2","key":"6044_CR19","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42(2):377\u2013381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010","journal-title":"J Biomed Inform"},{"issue":"7","key":"6044_CR20","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1007\/s00520-014-2143-1","volume":"22","author":"X Ma","year":"2014","unstructured":"Ma X, Zhang J, Zhong W, Shu C, Wang F, Wen J, Zhou M, Sang Y, Jiang Y, Liu L (2014) The diagnostic role of a short screening tool\u2014the distress thermometer: a meta-analysis. Support Care Cancer 22(7):1741\u20131755. https:\/\/doi.org\/10.1007\/s00520-014-2143-1","journal-title":"Support Care Cancer"},{"issue":"27","key":"6044_CR21","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1200\/jco.2013.54.8800","volume":"32","author":"BD Cheson","year":"2014","unstructured":"Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, Lister TA (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32(27):3059\u20133068. https:\/\/doi.org\/10.1200\/jco.2013.54.8800","journal-title":"J Clin Oncol"},{"issue":"5","key":"6044_CR22","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373\u2013383. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8","journal-title":"J Chronic Dis"},{"issue":"3","key":"6044_CR23","doi-asserted-by":"publisher","first-page":"267","DOI":"10.6004\/jnccn.2017.7048","volume":"16","author":"DT Jesse","year":"2018","unstructured":"Jesse DT, Carlos MC, Mary Ruth P, Greg PS, Amy PA, Thomas WL (2018) Patient-reported distress in myelodysplastic syndromes and its association with clinical outcomes: a retrospective cohort study. J Natl Compr Canc Netw 16(3):267\u2013273. https:\/\/doi.org\/10.6004\/jnccn.2017.7048","journal-title":"J Natl Compr Canc Netw"},{"issue":"3","key":"6044_CR24","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00277-013-1881-3","volume":"93","author":"N Vermaete","year":"2014","unstructured":"Vermaete N, Wolter P, Verhoef G, Gosselink R (2014) Physical activity and physical fitness in lymphoma patients before, during, and after chemotherapy: a prospective longitudinal study. Ann Hematol 93(3):411\u2013424. https:\/\/doi.org\/10.1007\/s00277-013-1881-3","journal-title":"Ann Hematol"},{"key":"6044_CR25","unstructured":"Cancer\u00ae Co (2012) Cancer Program Standards 2012: ensuring patient-centered care. American College of Surgeons. https:\/\/www.facs.org\/~\/media\/files\/quality%20programs\/cancer\/coc\/programstandards2012.ashx. Accessed 22 April 2020"},{"issue":"5","key":"6044_CR26","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1001\/journalofethics.2017.19.5.stas1-1705","volume":"19","author":"TW Leblanc","year":"2017","unstructured":"Leblanc TW, Kamal AH (2017) Assessing Psychological Toxicity and Patient-Reported Distress as the Sixth Vital Sign in Cancer Care and Clinical Trials. AMA J Ethics 19(5):460\u2013466","journal-title":"AMA J Ethics"},{"key":"6044_CR27","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1001\/jamainternmed.2015.6994","volume":"176","author":"TW LeBlanc","year":"2016","unstructured":"LeBlanc TW (2016) Addressing end-of-life quality gaps in hematologic cancers: the importance of early concurrent palliative care. JAMA Intern Med 176:265\u2013266","journal-title":"JAMA Intern Med"},{"issue":"9930","key":"6044_CR28","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/S0140-6736(13)62416-2","volume":"383","author":"C Zimmermann","year":"2014","unstructured":"Zimmermann C, Swami N, Krzyzanowska M, Hannon B, Leighl N, Oza A, Moore M, Rydall A, Rodin G, Tannock I, Donner A, Lo C (2014) Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet 383(9930):1721\u20131730. https:\/\/doi.org\/10.1016\/S0140-6736(13)62416-2","journal-title":"Lancet"},{"issue":"7","key":"6044_CR29","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1001\/jama.2009.1198","volume":"302","author":"M Bakitas","year":"2009","unstructured":"Bakitas M, Lyons KD, Hegel MT, Balan S, Brokaw FC, Seville J, Hull JG, Li Z, Tosteson TD, Byock IR, Ahles TA (2009) Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the PROJECT ENABLE II randomized controlled trial. JAMA 302(7):741\u2013749. https:\/\/doi.org\/10.1001\/jama.2009.1198","journal-title":"JAMA"},{"issue":"13","key":"6044_CR30","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1200\/JCO.2014.58.6362","volume":"33","author":"MA Bakitas","year":"2015","unstructured":"Bakitas MA, Tosteson TD, Li Z, Lyons KD, Hull JG, Li Z, Dionne-Odom JN, Frost J, Dragnev KH, Hegel MT, Azuero A, Ahles TA (2015) Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial. J Clin Oncol 33(13):1438\u20131445. https:\/\/doi.org\/10.1200\/JCO.2014.58.6362","journal-title":"J Clin Oncol"},{"issue":"20","key":"6044_CR31","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1001\/jama.2016.16786","volume":"316","author":"A El-Jawahri","year":"2016","unstructured":"El-Jawahri A, LeBlanc T, VanDusen H, Traeger L, Greer JA, Pirl WF, Jackson VA, Telles J, Rhodes A, Spitzer TR, McAfee S, Chen Y-BA, Lee SS, Temel JS (2016) Effect of inpatient palliative care on quality of life 2 weeks after hematopoietic stem cell transplantation: a randomized clinical trial. JAMA 316(20):2094\u20132103. https:\/\/doi.org\/10.1001\/jama.2016.16786","journal-title":"JAMA"},{"key":"6044_CR32","unstructured":"Goodman A (2017) Brief psychological interventions positively affect cancer patients\u2019 well being. The ASCO Post"},{"issue":"7","key":"6044_CR33","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1002\/cncr.21309","volume":"104","author":"BL Andersen","year":"2005","unstructured":"Andersen BL, Shapiro CL, Farrar WB, Crespin T, Wells-Digregorio S (2005) Psychological responses to cancer recurrence. Cancer 104(7):1540\u20131547. https:\/\/doi.org\/10.1002\/cncr.21309","journal-title":"Cancer"},{"issue":"1","key":"6044_CR34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/00002820-200302000-00002","volume":"26","author":"D Howell","year":"2003","unstructured":"Howell D, Fitch MI, Deane KA (2003) Women\u2019s experiences with recurrent ovarian cancer. Cancer Nurs 26(1):10\u201317. https:\/\/doi.org\/10.1097\/00002820-200302000-00002","journal-title":"Cancer Nurs"},{"issue":"5","key":"6044_CR35","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3322\/canjclin.39.5.305","volume":"39","author":"JW Worden","year":"1989","unstructured":"Worden JW (1989) The experience of recurrent cancer. CA Cancer J Clin 39(5):305\u2013310. https:\/\/doi.org\/10.3322\/canjclin.39.5.305","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"6044_CR36","first-page":"372","volume":"3","author":"SM Mahon","year":"1995","unstructured":"Mahon SM, Casperson DS (1995) Psychosocial concerns associated with recurrent cancer. Cancer Pract 3(6):372\u2013380","journal-title":"Cancer Pract"},{"issue":"4","key":"6044_CR37","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1300\/J077v03n04_03","volume":"3","author":"AD Weisman","year":"1986","unstructured":"Weisman AD, Worden JW (1986) The Emotional Impact of Recurrent Cancer. J Psychosoc Oncol 3(4):5\u201316. https:\/\/doi.org\/10.1300\/J077v03n04_03","journal-title":"J Psychosoc Oncol"},{"issue":"2","key":"6044_CR38","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1080\/07347332.2012.761318","volume":"31","author":"MM Step","year":"2013","unstructured":"Step MM, Kypriotakis GM, Rose JH (2013) An exploration of the relative influence of patient\u2019s age and cancer recurrence status on symptom distress, anxiety, and depression over time. J Psychosoc Oncol 31(2):168\u2013190. https:\/\/doi.org\/10.1080\/07347332.2012.761318","journal-title":"J Psychosoc Oncol"},{"issue":"1","key":"6044_CR39","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1080\/10410236.2011.527621","volume":"26","author":"MM Step","year":"2011","unstructured":"Step MM, Ray EB (2011) Patient Perceptions of oncologist\u2013patient communication about prognosis: changes from initial diagnosis to cancer recurrence. Health Commun 26(1):48\u201358. https:\/\/doi.org\/10.1080\/10410236.2011.527621","journal-title":"Health Commun"},{"issue":"21","key":"6044_CR40","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1056\/NEJM199211193272102","volume":"327","author":"GP Canellos","year":"1992","unstructured":"Canellos GP, Anderson JR, Propert KJ, Nissen N, Cooper MR, Henderson ES, Green MR, Gottlieb A, Peterson BA (1992) Chemotherapy of advanced Hodgkin\u2019s disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med 327(21):1478\u20131484. https:\/\/doi.org\/10.1056\/NEJM199211193272102","journal-title":"N Engl J Med"},{"issue":"10","key":"6044_CR41","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S1470-2045(16)30093-6","volume":"17","author":"S Kreissl","year":"2016","unstructured":"Kreissl S, Mueller H, Goergen H, Mayer A, Brillant C, Behringer K, Halbsguth TV, Hitz F, Soekler M, Shonukan O, Rueffer JU, Flechtner H-H, Fuchs M, Diehl V, Engert A, Borchmann P (2016) Cancer-related fatigue in patients with and survivors of Hodgkin\u2019s lymphoma: a longitudinal study of the German Hodgkin Study Group. Lancet Oncol 17(10):1453\u20131462. https:\/\/doi.org\/10.1016\/S1470-2045(16)30093-6","journal-title":"Lancet Oncol"},{"issue":"12","key":"6044_CR42","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/S1470-2045(09)70258-X","volume":"10","author":"N Heutte","year":"2009","unstructured":"Heutte N, Flechtner HH, Mounier N, Mellink WAM, Meerwaldt JH, Eghbali H, van't Veer MB, Noordijk EM, Kluin-Nelemans JC, Lampka E, Thomas J, Lugtenburg PJ, Viterbo L, Carde P, Hagenbeek A, van der Maazen RWM, Smit WGJM, Brice P, van Marwijk KM, Baars JW, Poortmans P, Tirelli U, Leeksma OC, Tom\u0161i\u010d R, Feugier P, Salles G, Gabarre J, Kersten MJ, Van Den Neste E, Creemers G-JM, Gaillard I, Meijnders P, Tertian G, Reman O, Muller HP, Troncy J, Blanc M, Schroyens W, Voogt PJ, Wijermans P, Rieux C, Ferm\u00e9 C, Henry-Amar M (2009) Quality of life after successful treatment of early-stage Hodgkin\u2019s lymphoma: 10-year follow-up of the EORTC\u2013GELA H8 randomised controlled trial. Lancet Oncol 10(12):1160\u20131170. https:\/\/doi.org\/10.1016\/S1470-2045(09)70258-X","journal-title":"Lancet Oncol"},{"issue":"4","key":"6044_CR43","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/bjc.2013.779","volume":"110","author":"LA Dani\u00ebls","year":"2014","unstructured":"Dani\u00ebls LA, Oerlemans S, Krol ADG, Creutzberg CL, van de Poll-Franse LV (2014) Chronic fatigue in Hodgkin lymphoma survivors and associations with anxiety, depression and comorbidity. Br J Cancer 110(4):868\u2013874. https:\/\/doi.org\/10.1038\/bjc.2013.779","journal-title":"Br J Cancer"},{"key":"6044_CR44","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/1097-0142(19890201)63:3<604::AID-CNCR2820630334>3.0.CO;2-2","volume":"63","author":"RR Love","year":"1989","unstructured":"Love RR, Leventhal H, Easterling D, Nerenz DR (1989) Side effects and emotional distress during cancer chemotherapy. Cancer 63:60\u2013612","journal-title":"Cancer"},{"key":"6044_CR45","doi-asserted-by":"crossref","unstructured":"DiMatteo MR, Haskard-Zolnierek KB (2011) Impact of depression on treatment adherence and survival from cancer. In: Depression and cancer. World Psychiatric Association titles on depression. Wiley-Blackwell, pp 101\u2013124","DOI":"10.1002\/9780470972533.ch5"},{"issue":"32","key":"6044_CR46","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1200\/JCO.2017.73.2800","volume":"35","author":"A El-Jawahri","year":"2017","unstructured":"El-Jawahri A, Traeger L, Greer JA, VanDusen H, Fishman SR, LeBlanc TW, Pirl WF, Jackson VA, Telles J, Rhodes A, Li Z, Spitzer TR, McAfee S, Chen Y-BA, Temel JS (2017) Effect of inpatient palliative care during hematopoietic stem-cell transplant on psychological distress 6 months after transplant: results of a randomized clinical trial. J Clin Oncol 35(32):3714\u20133721. https:\/\/doi.org\/10.1200\/JCO.2017.73.2800","journal-title":"J Clin Oncol"},{"issue":"5","key":"6044_CR47","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.pec.2016.12.009","volume":"100","author":"A Ugalde","year":"2017","unstructured":"Ugalde A, Haynes K, Boltong A, White V, Krishnasamy M, Schofield P, Aranda S, Livingston P (2017) Self-guided interventions for managing psychological distress in people with cancer \u2013 a systematic review. Patient Educ Couns 100(5):846\u2013857. https:\/\/doi.org\/10.1016\/j.pec.2016.12.009","journal-title":"Patient Educ Couns"},{"issue":"6","key":"6044_CR48","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/sj.bjc.6603626","volume":"96","author":"V Strong","year":"2007","unstructured":"Strong V, Waters R, Hibberd C, Rush R, Cargill A, Storey D, Walker J, Wall L, Fallon M, Sharpe M (2007) Emotional distress in cancer patients: the Edinburgh Cancer Centre symptom study. Br J Cancer 96(6):868\u2013874. https:\/\/doi.org\/10.1038\/sj.bjc.6603626","journal-title":"Br J Cancer"},{"issue":"5","key":"6044_CR49","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1080\/j.1440-1614.2000.00817.x","volume":"34","author":"S Pascoe","year":"2000","unstructured":"Pascoe S, Edelman S, Kidman A (2000) Prevalence of psychological distress and use of support services by cancer patients at Sydney hospitals. Aust N Z J Psychiatry 34(5):785\u2013791. https:\/\/doi.org\/10.1080\/j.1440-1614.2000.00817.x","journal-title":"Aust N Z J Psychiatry"},{"issue":"5","key":"6044_CR50","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.cllc.2017.02.008","volume":"18","author":"EJ Morrison","year":"2017","unstructured":"Morrison EJ, Novotny PJ, Sloan JA, Yang P, Patten CA, Ruddy KJ, Clark MM (2017) Emotional problems, quality of life, and symptom burden in patients with lung cancer. Clin Lung Cancer 18(5):497\u2013503. https:\/\/doi.org\/10.1016\/j.cllc.2017.02.008","journal-title":"Clin Lung Cancer"},{"issue":"6","key":"6044_CR51","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/s0277-9536(98)00402-x","volume":"48","author":"CE Bird","year":"1999","unstructured":"Bird CE, Rieker PP (1999) Gender matters: an integrated model for understanding men\u2019s and women\u2019s health. Soc Sci Med 48(6):745\u2013755. https:\/\/doi.org\/10.1016\/s0277-9536(98)00402-x","journal-title":"Soc Sci Med"},{"key":"6044_CR52","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2307\/2096424","volume":"60","author":"J Mirowsky","year":"1995","unstructured":"Mirowsky J, Ross C (1995) Sex differences in distress: real or artifact? Am Sociol Rev 60:449. https:\/\/doi.org\/10.2307\/2096424","journal-title":"Am Sociol Rev"},{"issue":"6","key":"6044_CR53","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1080\/028418699432905","volume":"38","author":"MKG Henrich","year":"1999","unstructured":"Henrich MKG (1999) Illness-related distress: does it mean the same for men and women?: gender aspects in cancer patients\u2019 distress and adjustment. Acta Oncol 38(6):747\u2013755. https:\/\/doi.org\/10.1080\/028418699432905","journal-title":"Acta Oncol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-021-06044-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-021-06044-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-021-06044-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T10:15:48Z","timestamp":1626862548000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-021-06044-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,11]]},"references-count":53,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["6044"],"URL":"https:\/\/doi.org\/10.1007\/s00520-021-06044-9","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"type":"print","value":"0941-4355"},{"type":"electronic","value":"1433-7339"}],"subject":[],"published":{"date-parts":[[2021,2,11]]},"assertion":[{"value":"13 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Duke University Institutional Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Being a secondary analysis of a retrospective chart review study, there were no study participants, just data. As such, no consent was obtained nor required by the IRB.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"N\/A","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Jesse D. Troy: Consulting services to the Community Data Roundtable, AegisCN, Gamida Cell, The EMMES Corporation, Sino Cell Technologies, Cohortias, International, and Synthetic Biologics unrelated to this work.Thomas W. LeBlanc: Personal fees for consulting or advisory boards from AbbVie, Agios, AstraZeneca, Amgen, Carevive, BMS\/Celgene, Daiichi-Sankyo, Heron, Otsuka, Pfizer, and Seattle Genetics; royalties from UpToDate; speakers bureau fees from Agios, AbbVie, and BMS\/Celgene; grants and\/or research contracts from the American Cancer Society, AstraZeneca, BMS, Jazz Pharmaceuticals, the NINR\/NIH, and Seattle Genetics.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All analyses were done using SAS v9.4 (SAS Institute, Cary, NC). Code can be made available from the statistician upon request.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}